The dietary compound luteolin inhibits pancreatic cancer growth by targeting BCL-2
-
- Zhimei Li
- Hubei Key Laboratory of Natural Medicinal Chemistry and Resource Evaluation
-
- Yiyuan Zhang
- Hubei Key Laboratory of Natural Medicinal Chemistry and Resource Evaluation
-
- Lixia Chen
- Wuya College of Innovation
-
- Hua Li
- Hubei Key Laboratory of Natural Medicinal Chemistry and Resource Evaluation
説明
<p>Luteolin, a bioactive flavonoid from celery (<italic>Apium graveolens</italic>), has been rationally proved to trigger SW1990 cells to apoptosis by targeting BCL-2, and may serve as a potential agent for this cancer therapy.</p>
収録刊行物
-
- Food & Function
-
Food & Function 9 (5), 3018-3027, 2018
Royal Society of Chemistry (RSC)
